07:46:57 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-05-30 Bokslutskommuniké 2024
2024-02-29 Kvartalsrapport 2024-Q3
2023-12-04 Kvartalsrapport 2024-Q2
2023-10-04 Ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 Årsstämma 2024
2023-08-31 Kvartalsrapport 2024-Q1
2023-06-08 Bokslutskommuniké 2023
2023-03-01 Kvartalsrapport 2023-Q3
2022-12-01 Kvartalsrapport 2023-Q2
2022-10-03 Ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 Årsstämma 2023
2022-08-31 Kvartalsrapport 2023-Q1
2022-06-10 Bokslutskommuniké 2022
2022-03-02 Kvartalsrapport 2022-Q3
2021-12-02 Kvartalsrapport 2022-Q2
2021-09-09 Ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 Kvartalsrapport 2022-Q1
2021-05-31 Bokslutskommuniké 2021
2021-03-03 Kvartalsrapport 2021-Q3
2020-12-02 Kvartalsrapport 2021-Q2
2020-09-30 Årsstämma 2021
2020-09-09 Ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 Kvartalsrapport 2021-Q1
2020-06-08 Bokslutskommuniké 2020
2020-04-20 Extra Bolagsstämma 2020
2020-03-02 Kvartalsrapport 2020-Q3
2019-12-02 Kvartalsrapport 2020-Q2
2019-09-30 Årsstämma 2020
2019-09-25 Ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 Kvartalsrapport 2020-Q1
2019-06-10 Bokslutskommuniké 2019
2019-03-04 Kvartalsrapport 2019-Q3
2018-12-17 Kvartalsrapport 2019-Q2
2018-09-25 Ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 Årsstämma 2019
2018-09-24 Kvartalsrapport 2019-Q1
2018-06-25 Bokslutskommuniké 2018
2018-03-26 Kvartalsrapport 2018-Q3
2017-12-18 Kvartalsrapport 2018-Q2
2017-09-25 Årsstämma 2018
2017-09-25 Kvartalsrapport 2018-Q1
2017-06-30 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Idag utvecklar bolaget system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.
2022-05-02 08:45:00

Mölndal, Sweden, May 2[nd], 2022 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that Hannover Medical School has expanded its treatment arsenal and implemented OPRA[TM] Implant System in clinical use. The first surgeries with the technique have successfully been completed and the hospital will continue to offer the treatment to suitable patients with above-knee, arm, and digit amputations.

Hannover Medical School is the hospital that has tradition with osseointegration in Germany. In October 2022 the new chief of the trauma department - Prof. Stephan Sehmisch- established a new division for Innovations in Amputee Medicine for the best care of amputees. Since December 2021, the hospital has offered Integrum's OPRA™ Implant System. Two patients, one arm amputee and one leg amputee, have successfully been treated so far.

"Integrum's OPRA™ Implant System is a much-welcomed complement to our treatment arsenal. With the OPRA™ Implant System, we now have further options to offer our amputees, and I look forward to also being able to treat patients with arm or digit amputations. This innovative implant system will help many of our patients back to an active life," says Dr. Jennifer Ernst, the surgeon performing the first procedures at Hannover Medical School.

Hannover Medical School is the latest among several new hospitals to offer Integrum's OPRA™ Implant System in Germany. 

"We are delighted to learn about yet another successful clinical implementation of our advanced bone-anchored implants. It is a great acknowledgment of our implant system that Hannover Medical School now chooses to expand their established treatment arsenal and implement our products in clinical use," comments María López, Integrum's CEO.

Integrum's OPRA[TM] Implant System is a bone-anchored system based on osseointegration. As the prostheses are directly attached to the bone, the use of a socket is avoided, leading to fewer complications and better quality of life for the patient.